Andreas Kranzusch

Andreas Kranzusch has a diverse work experience, primarily in finance and management roles. Andreas started their career at Deutsche Bank Corporate Banking, where they worked as a Manager from 1992 to 2000. After that, they joined greenovation Biotech as CFO and Managing Director from 2001 to 2009. During this time, they played a crucial role in the company's financial management.

In 2009, Andreas founded Emcid Biotech GmbH, a small biotech start-up focusing on plant-based industrial biotech. Andreas served as the Founder and Managing Director, overseeing the identification and utilization of natural products for fine chemicals.

Simultaneously, Andreas also established Kranzusch Corporate Services in 2009, where they provided CFO services and held Head of Finance positions for various start-ups. Andreas was responsible for leading a team, developing business strategies, implementing reporting tools and structures, financial project management, and business planning. Their company was associated with ulbrich & partner Management Consulting.

From 2014 to 2017, Andreas worked at Coadvertise GmbH as CFO, contributing to the company's financial management. Andreas then joined Cardior Pharmaceuticals in 2016 as Head of Finance.

In 2020, Andreas took on the role of CFO at MODAG, a company specializing in disease-modifying therapies for neurodegenerative disorders. Andreas also served as CFO / Managing Director at Allecra Therapeutics, involving himself in financial and managerial matters to enhance the company's performance.

Most recently, in 2022, Andreas began working at LAMPseq Diagnostics as CFO, focusing on finance and strategic planning. Throughout their career, Andreas Kranzusch has accumulated extensive experience in financial management, strategy development, and leadership.

Andreas Kranzusch pursued their education in Computer Science from 1987 to 1992 at Technische Universität Dresden, earning a degree, Dipl. (Diploma).